Morepen Laboratories Ltd buy melinda
Start price
11.09.17
/
50%
?0.23
Target price
14.11.17
€0.30
Performance (%)
11.90%
End price
14.11.17
€0.26
Summary
This prediction ended on 14.11.17 with a price of €0.26. The prediction had a final performance of 11.90%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Morepen Laboratories Ltd | - | - | - | - |
iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by melinda for this prediction
In the thread Morepen Laboratories Ltd diskutieren
LABOR
Morepen Laboratories of India
11. September (Reuters) - Morepen Laboratories Ltd: Juni - Quartal Nettogewinn von 19,6 Millionen Rupien verglichen mit einem Gewinn von 29,8 Millionen Rupien vor einem Jahr. Die Gesamterträge der Juni - Quartal 1,24 Milliarden Rupien gegen 1,21 Milliarden Rupien vor einem Jahr.
(Vom Mitglied beendet)